Literature DB >> 12799024

Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome.

K-M Myhr1, K S Vågnes, T H Marøy, J H Aarseth, H I Nyland, C A Vedeler.   

Abstract

Interleukin-10 (IL-10) may have both pro- and anti-inflammatory effects in Guillain-Barré syndrome (GBS). The distribution of polymorphisms in the IL-10 gene (-1082 (G/A), -819 (T/C) and -592 (A/C)) was analysed to determine whether they could influence disease susceptibility or clinical course in GBS. The -592 CC and -819 CC genotypes associated with increased IL-10 response were more frequent in the GBS patients than in the controls (P=0.027), but the polymorphisms did not influence the clinical course of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799024     DOI: 10.1016/s0165-5728(03)00133-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Authors:  Natalia Paladino; Hugo Fainboim; Graciela Theiler; Teresa Schroder; Alberto Eduardo Muñoz; Ana Claudia Flores; Omar Galdame; Leonardo Fainboim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk.

Authors:  Hong Jiao; Weizhi Wang; Huabing Wang; Yun Wu; Lihua Wang
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

Review 3.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

Review 4.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 5.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

Review 6.  Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.

Authors:  Kishan Kumar Nyati; Kashi Nath Prasad
Journal:  Mediators Inflamm       Date:  2014-09-22       Impact factor: 4.711

7.  Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh.

Authors:  Israt Jahan; Rijwan U Ahammad; Mir M Khalid; Mohammad I Rahman; Shoma Hayat; Badrul Islam; Quazi D Mohammad; Zhahirul Islam
Journal:  Ann Clin Transl Neurol       Date:  2019-03-03       Impact factor: 4.511

8.  Association between the IL-10 and IL-6 polymorphisms and brucellosis susceptibility: a meta-analysis.

Authors:  Xiaochun Jin; Yueyuan Wu; Shuzhou Yin; Xu Chen; Youtao Zhang
Journal:  BMC Med Genet       Date:  2020-03-30       Impact factor: 2.103

Review 9.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

10.  Association between the IL-10-1082G/A, IL-10-819T/C and IL-10-592A/C polymorphisms and Brucellosis susceptibility: a meta-analysis.

Authors:  Xiaochun Jin; Shuzhou Yin; Youtao Zhang
Journal:  Epidemiol Infect       Date:  2019-12-11       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.